ITeos Therapeutics Inc (NASDAQ:ITOS) price on Friday, February 28, rose 3.71% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.26.
A look at the stock’s price movement, the close in the last trading session was $7.00. Turning to its 52-week performance, $18.75 and $6.94 were the 52-week high and 52-week low respectively. Overall, ITOS moved -3.07% over the past month.
ITeos Therapeutics Inc’s market cap currently stands at around $265.24 million, with investors looking forward to this quarter’s earnings report slated for in April.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 35M, representing a 177.89% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ITOS is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ITOS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ITOS’s current price about -1.48% and -3.72% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 45.46, while 7-day volatility ratio is 4.35% and 3.86% in the 30-day chart. Further, ITeos Therapeutics Inc (ITOS) has a beta value of 1.39, and an average true range (ATR) of 0.28. Analysts have given the company’s stock an average 52-week price target of $36, forecast between a low of $36 and high of $36. Looking at the price targets, the low is -395.87% off current price level while to achieve the yearly target high, price needs to move -395.87%. Nonetheless, investors will most likely welcome a -395.87% jump to $36 which is the analysts’ median price.
If we refocus on ITeos Therapeutics Inc (NASDAQ:ITOS), historical trading data shows that trading volumes averaged 354.24K over the past 3 months. The company’s latest data on shares outstanding shows there are 36.53 million shares.
The 13.20% of ITeos Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 81.84% of the company’s shares. Current price change has pushed the stock -5.47% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ITOS stock continues to rise going into the next quarter.
